AF
ELV icon

Avanza Fonder’s Elevance Health ELV Stock Holding History

Avanza Fonder’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.76M Sell
14,882
-4,652
-24% -$1.73M 0.13% 156
2026
Q1 		$5.72M Buy
19,534
+2,936
+18% +$965K 0.16% 132
2025
Q4 		$5.82M Hold
16,598
– – 0.15% 135
2025
Q3 		$5.36M Buy
16,598
+1,493
+10% +$464K 0.14% 129
2025
Q2 		$5.88M Hold
15,105
– – 0.17% 106
2025
Q1 		$6.49M Sell
15,105
-2,764
-15% -$1.11M 0.21% 92
2024
Q4 		$6.59M Buy
+17,869
New +$7.48M 0.2% 90

Other funds holding ELV

HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
FI
Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Avanza Fonder's ELV Position: Q2 2026 in Review

Avanza Fonder reduced its Elevance Health (ELV) stake by 24% in Q2 2026, selling an estimated $1.73M and leaving 14,882 shares worth $5.76M. The position accounts for 0.13% of the portfolio, ranked #156.

Avanza Fonder first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.59M in Q4 2024. 513 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Avanza Fonder held 14,882 shares of Elevance Health worth $5.76M as of Q2 2026.
  • Avanza Fonder sold 4,652 Elevance Health shares in Q2 2026, an estimated $1.73M.
  • Elevance Health made up 0.13% of Avanza Fonder's portfolio in Q2 2026, its #156 holding.
  • Avanza Fonder first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • Avanza Fonder's Elevance Health position peaked at $6.59M in Q4 2024.
  • 513 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Avanza Fonder's 13F filing for Q2 2026, filed 17 Jul 2026.